Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report.

Meyers DE, Hill WF, Suo A, Jimenez-Zepeda V, Cheng T, Nixon NA

Open source

DOI
10.1186/s40164-018-0098-5
Published
2018
Container
Experimental hematology & oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40164-018-0098-5,
  title = {Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report.},
  author = {Meyers DE and Hill WF and Suo A and Jimenez-Zepeda V and Cheng T and Nixon NA},
  year = {2018},
  journal = {Experimental hematology \& oncology},
  doi = {10.1186/s40164-018-0098-5},
  url = {https://doi.org/10.1186/s40164-018-0098-5}
}

RIS

TY  - JOUR
TI  - Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report.
AU  - Meyers DE
AU  - Hill WF
AU  - Suo A
AU  - Jimenez-Zepeda V
AU  - Cheng T
AU  - Nixon NA
PY  - 2018
JO  - Experimental hematology & oncology
DO  - 10.1186/s40164-018-0098-5
UR  - https://doi.org/10.1186/s40164-018-0098-5
ER  - 

APA

DE, M., WF, H., A, S., V, J., T, C., & NA, N. (2018). Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report.. Experimental hematology & oncology. https://doi.org/10.1186/s40164-018-0098-5

Source records